Benefits
Satiety / Snacking Reduction
Csat+ designed for satiety and reduction of between-meal snacking; mechanism may involve mood-satiety interaction.
Food Craving Control
Saffron's mood effects extend to emotional eating contexts where mood and food cravings are linked. Csat+ targets this connection.
Weight Management Adjunct
Reduced snacking and food cravings support comprehensive weight management. Adjunct to caloric awareness and lifestyle approach.
Metabolic Effect
Pharmactive positioning includes 'satiating metabolic effect' — combining satiety and metabolic support.
Saffron Mood Component
Same Pharmactive saffron base as Affron® — mood support component relevant to emotional/stress eating patterns.
Mechanism of action
Mood-Satiety Pathway Interaction
Mood and food cravings are biologically linked — emotional eating, stress eating, and mood-related snacking are common patterns. Saffron's serotonergic activity may modulate both mood and food-related behaviors.
Hypothalamic Appetite Modulation (Theoretical)
Saffron compounds may modulate hypothalamic appetite control; specific Csat+ mechanism per Pharmactive research.
Standardized Crocins/Safranal
Same standardization framework as other Pharmactive saffron products; specific dose/standardization for satiety applications.
Clinical trials
Pharmactive clinical studies of Csat+ for satiety and weight management.
Adults with weight management concerns.
Satiating metabolic effect demonstrated in clinical trials.
Studies of saffron extracts on snacking behavior.
Adults with snacking/emotional eating concerns.
Reduced snacking and food craving in saffron-supplemented vs placebo groups.
About this ingredient
CSAT+® is a SAFFRON EXTRACT FOR SATIETY AND METABOLIC EFFECT developed by PHARMACTIVE BIOTECH PRODUCTS (Spain). Distinguished from Pharmactive's other saffron products (Affron® for mood, AffronEYE® for eye health) by specific positioning for satiety, food cravings, and metabolic applications. POSITIONING: 'achieves satiating metabolic effect.' EVIDENCE-BASED USES: (1) Satiety / snacking reduction; (2) Food craving control; (3) Weight management adjunct; (4) Emotional/stress eating support; (5) Saffron mood-satiety pathway interaction.
CRITICAL CAUTIONS: (1) WEIGHT MANAGEMENT FRAMEWORK — caloric deficit, exercise, behavior change foundational; Csat+ one tool; (2) EMOTIONAL EATING — for established emotional eating patterns, behavioral therapy may be foundational; supplements adjunct; (3) PREGNANCY — saffron generally cautioned in pregnancy; AVOID; (4) ANTIDEPRESSANT INTERACTION — theoretical serotonergic additive effects; modest concern; (5) DOSE — per Pharmactive product specification; (6) CSAT+ vs OTHER PHARMACTIVE SAFFRON — Affron® for mood, AffronEYE® for eye health, Csat+ for satiety; same plant source, different standardization/dose for different applications; (7) CSAT+ vs APPETITE-CONTROL ALTERNATIVES — different mechanism than Caralluma fimbriata (Slimaluma), glucomannan/konjac, PHGG (Sunfiber); saffron's mood-mediated approach distinct; (8) SNACKING-FOCUSED USE — particularly relevant for those whose weight challenge is between-meal snacking driven by mood/emotional triggers; (9) DURATION — effects build over several weeks; not immediate; (10) BRAND VERIFICATION — Csat+® is Pharmactive trademark; clinical evidence specific to this standardized form.